Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent

Transfusion-associated iron overload induces systemic toxicity. Deferasirox, a convenient long acting oral agent, has recently been introduced in clinical practice with a promising efficacy. But there are some patients who experience drug-related toxicities and cannot tolerate it. To investigate effect of genetic variations on the toxicities and find optimal target population, we analyzed the genetic polymorphisms of UDP-glucuronosyltransferase 1A (UGT1A) subfamily, multi-drug resistance-associated protein 2 (MRP2) and breast cancer resistance protein (BCRP). A total of 20 functional genetic polymorphisms were analyzed in 98 patients who received deferasirox to reduce transfusion-induced iron overload. We retrospectively reviewed the medical records to find out the drug-related toxicities. Fifteen (15.3%) patients developed hepatotoxicity. Patients without wild-type allele carrying two MRP2 haplotypes containing −1774 del and/or −24T were at increased risk of developing hepatotoxicity compared to patients with the wild-type allele on multivariate analysis (OR = 7.17, 95% CI = 1.79–28.67, P = 0.005). Creatinine elevation was observed in 9 patients (9.2%). Body weight ≥40 kg and homozygosity for UGT1A1*6 were risk factors of creatinine elevation (OR = 8.48, 95% CI = 1.7–43.57, P = 0.010 and OR = 14.17, 95% CI = 1.34–150.35, P = 0.028). Our results indicate that functional genetic variants of enzymes to metabolize and transport deferasirox are associated with drug-related toxicities. Further studies are warranted to confirm the results as the pharmacogenetic biomarkers of deferasirox.

• Publication year

  2010

• Venue

  PLoS ONE

• Publication date

  2010-11-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pone.0064114PMID 23737969PMCID 3667856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Observational study comparing long‐term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation‐naïve children with transfusional iron overload

  2012cited by this paper
• Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

  2011cited by this paper
• UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer

  2011cited by this paper
• Deferasirox induced liver injury in haemochromatosis.

  2011cited by this paper
• Genotype‐directed, dose‐finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms

  2011cited by this paper
• Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients

  2011cited by this paper
• Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

  2011cited by this paper
• ABCC2/Abcc2: a multispecific transporter with dominant excretory functions

  2010cited by this paper
• Deferasirox induced liver injury in haemochromatosis.

  2010cited by this paper
• Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

  2010cited by this paper
• Efficacy and safety of deferiprone (Ferriprox), an oral iron-chelating agent, in pediatric patients

  2010cited by this paper
• Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children

  2009cited by this paper
• National Center for Biotechnology Information

  2008cited by this paper
• Pharmacokinetics, Distribution, Metabolism, and Excretion of Deferasirox and Its Iron Complex in Rats

  2008cited by this paper
• Update on toxicity and efficacy aspects of treatment with deferasirox and its implication on the morbidity and mortality of transfused iron loaded patients.

  2008cited by this paper
• Genetic Variations and Haplotypes of UDP-glucuronosyltransferase 1A Locus in a Korean Population

  2008cited by this paper
• Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy.

  2008cited by this paper
• MRP2 haplotypes confer differential susceptibility to toxic liver injury

  2007cited by this paper
• Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation.

  2007cited by this paper
• Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

  2007cited by this paper
• Early clinical impact of iron overload in stem cell transplantation. A prospective study

  2007cited by this paper
• Identification and Functional Assessment of BCRP Polymorphisms in a Korean Population

  2007cited by this paper
• Recent Developments in Iron Chelation Therapy

  2007cited by this paper
• Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia.

  2007cited by this paper
• A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

  2007cited by this paper
• Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

  2007cited by this paper
• Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities

  2007cited by this paper
• Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin.

  2006cited by this paper
• Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice

  2006cited by this paper
• Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

  2006cited by this paper
• A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

  2006cited by this paper
• Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

  2006cited by this paper
• Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

  2006cited by this paper
• Role of the breast cancer resistance protein (ABCG2) in drug transport

  2005cited by this paper
• Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress

  2004cited by this paper
• Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias.

  2003cited by this paper
• Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

  2002cited by this paper
• A new statistical method for haplotype reconstruction from population data.

  2001cited by this paper
• Clinical pharmacokinetics and metabolism of irinotecan (CPT-11).

  2001cited by this paper
• Secondary iron overload.

  2001cited by this paper
• Pathogenesis of liver fibrosis: role of oxidative stress.

  2000cited by this paper
• BMT: Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study.

  2000cited by this paper
• Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study.

  1999cited by this paper
• [Secondary iron overload].

  1998cited by this paper
• Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

  1998cited by this paper
• Iron-chelating therapy and the treatment of thalassemia.

  1997cited by this paper
• On measures of gametic disequilibrium.

  1988cited by this paper

• Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion‐Dependent Thalassemia Identified Using Whole‐Genome Sequencing

  2025influential citation
• Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications

  2024cites this paper
• Sex and Gender Differences in Iron Chelation

  2024cites this paper
• Case report: Acute liver failure during deferasirox therapy and the potential role of pharmacogenetics

  2024influential citation
• Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.

  2023cites this paper
• Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis

  2023influential citation
• Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

  2022cites this paper
• Hepcidin in Children and Adults with Acute Leukemia or Undergoing Hematopoietic Cell Transplantation: A Systematic Review

  2022cites this paper
• From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox

  2021cites this paper
• Effect of Genetic Polymorphisms on the Pharmacokinetics of Deferasirox in Healthy Chinese Subjects and an Artificial Neural Networks Model for Pharmacokinetic Prediction

  2020cites this paper
• The challenges of handling deferasirox in sickle cell disease patients older than 40 years

  2019cites this paper
• ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects

  2019cites this paper
• Significant Hyperbilirubinemia and Acute Hepatocellular Jaundice in a Pediatric Patient Receiving Deferasirox: A Case Report.

  2018cites this paper
• Deferasirox associated with liver failure and death in a sickle cell anemia patient homozygous for the −1774delG polymorphism in the Abcc2 gene

  2017cites this paper
• Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients.

  2017cites this paper
• Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome*

  2017cites this paper
• Autophagy as a potential target for sarcoma treatment.

  2017cites this paper
• TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells

  2017cites this paper
• Deferasirox pharmacokinetic evaluation in β‐thalassaemia paediatric patients

  2017cites this paper
• Production of Recombinant Anti-Cancer Vaccines in Plants

  2017cites this paper
• The questioning for routine monthly monitoring of proteinuria in patients with β-thalassemia on deferasirox chelation

  2017cites this paper
• Fusion Peptide Improves Stability and Bioactivity of Single Chain Antibody against Rabies Virus.

  2017cites this paper
• PSN-PC: A Novel Antimicrobial and Anti-Biofilm Peptide from the Skin Secretion of Phyllomedusa-camba with Cytotoxicity on Human Lung Cancer Cell

  2017cites this paper
• Combining Click Chemistry-Based Proteomics With Dox-Inducible Gene Expression.

  2017cites this paper
• Antibodies from plants for bionanomaterials.

  2017cites this paper
• Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity

  2017cites this paper
• Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome

  2016cites this paper
• The Impact of Fluid Inertia on In Vivo Estimation of Mitral Valve Leaflet Constitutive Properties and Mechanics

  2016cites this paper
• Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

  2016cites this paper
• CRISPR interference-guided balancing of a biosynthetic mevalonate pathway increases terpenoid production.

  2016cites this paper
• TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells

  2016cites this paper
• Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy

  2016cites this paper
• Combined effect of diet and cervical microbiome on the risk of cervical intraepithelial neoplasia.

  2016cites this paper
• Cortactin promotes exosome secretion by controlling branched actin dynamics

  2016cites this paper
• Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis

  2016cites this paper
• Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico

  2016cites this paper
• Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV‐positive women

  2016cites this paper
• In Vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model

  2016cites this paper
• Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women

  2016cites this paper
• Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota

  2016cites this paper
• Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption

  2016cites this paper
• Prevalence and genotype distribution of human papillomavirus among Hakka women in China.

  2016cites this paper
• Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles

  2016cites this paper
• Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model

  2016cites this paper
• RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis

  2016cites this paper
• The functions and clinical applications of tumor-derived exosomes

  2016cites this paper
• Solution NMR studies on Helicobacter pylori proteins for antibiotic target discovery

  2016cites this paper
• Moving forward with human papillomavirus immunotherapies

  2016cites this paper
• RGS10 Negatively Regulates Platelet Activation and Thrombogenesis

  2016cites this paper
• Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles

  2016cites this paper
• Mechanisms of mesenchymal stem/stromal cell function

  2016cites this paper
• The Regulatory Roles of ncRNA Rli60 in Adaptability of Listeria monocytogenes to Environmental Stress and Biofilm Formation

  2016cites this paper
• Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species

  2016cites this paper
• Cardiac Light-Sheet Fluorescent Microscopy for Multi-Scale and Rapid Imaging of Architecture and Function

  2016cites this paper
• Extracellular vesicle proteomes reflect developmental phases of Bacillus subtilis

  2016cites this paper
• Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis

  2016cites this paper
• Exosomes from high glucose-treated glomerular endothelial cells activate mesangial cells to promote renal fibrosis

  2016cites this paper
• Extracellular Vesicles in Physiology, Pathology, and Therapy of the Immune and Central Nervous System, with Focus on Extracellular Vesicles Derived from Mesenchymal Stem Cells as Therapeutic Tools

  2016cites this paper
• Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice

  2016cites this paper
• The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?

  2016cites this paper
• Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth

  2016cites this paper
• Cross Talk between Cancer and Mesenchymal Stem Cells through Extracellular Vesicles Carrying Nucleic Acids

  2016cites this paper
• 3D Finite Element Electrical Model of Larval Zebrafish ECG Signals

  2016cites this paper
• Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer.

  2016cites this paper
• Obstetric complications after treatment of cervical intraepithelial neoplasia.

  2016cites this paper
• Role of pharmacogenetics on deferasirox AUC and efficacy.

  2016cites this paper
• The secretome of periodontal ligament stem cells from MS patients protects against EAE

  2016cites this paper
• Combination therapy with metformin and coenzyme Q10 in murine experimental autoimmune arthritis

  2016cites this paper
• The roles of noncoding RNA Rli60 in regulating the virulence of Listeria monocytogenes.

  2016cites this paper
• Deferasirox pharmacokinetic and toxicity correlation in β‐thalassaemia major treatment

  2016cites this paper
• Stratified Medicine: Maximizing Clinical Benefit by Biomarker-Driven Health Care.

  2016cites this paper
• Caviibacter abscessus gen. nov., sp. nov., a member of the family Leptotrichiaceae isolated from guinea pigs (Cavia porcellus).

  2016cites this paper
• Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration

  2016cites this paper
• Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation

  2016cites this paper
• The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.

  2016cites this paper
• Health Behaviors in Cervical Cancer Survivors and Associations with Quality of Life.

  2016cites this paper
• Live imaging and modeling for shear stress quantification in the embryonic zebrafish heart.

  2016cites this paper
• Cerebral activation effects of acupuncture using Zusanli (ST36) and Yanglingquan (GB34) points based on Regional Homogeneity indices: A resting-state fMRI study

  2016cites this paper
• Determination of deferasirox in human plasma by short-end injection and sweeping with a field-amplified sample stacking and micellar electrokinetic chromatography.

  2016cites this paper
• Advance in the study on p38 MAPK mediated drug resistance in leukemia.

  2016cites this paper
• Reconstitution of TGFBR2 in HCT116 colorectal cancer cells causes increased LFNG expression and enhanced N-acetyl-d-glucosamine incorporation into Notch1.

  2016cites this paper
• ROS/oxidative stress signaling in osteoarthritis.

  2016cites this paper
• Interferon‐γ, but Not Interleukin‐4, Suppresses Experimental Polymyositis

  2016cites this paper
• Deferasirox and children: From clinical trials to the real world

  2016cites this paper
• A polymorphism in FASL is associated with rituximab response in follicular lymphoma patients

  2016cites this paper
• Over-expression of fHbp in Arabdopsis for development of meningococcal serogroup B subunit vaccine.

  2016cites this paper
• Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study

  2016cites this paper
• Tangeretin derivative, 5-acetyloxy-6,7,8,4′-tetramethoxyflavone induces G2/M arrest, apoptosis and autophagy in human non-small cell lung cancer cells in vitro and in vivo

  2016cites this paper
• A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells.

  2016cites this paper
• Extracts from Dendropanax morbifera Leaves Have Modulatory Effects on Neuroinflammation in Microglia.

  2016cites this paper
• Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century

  2015cites this paper
• Role of Regulators of G Protein Signaling Proteins in Bone Physiology and Pathophysiology.

  2015cites this paper
• Efficacy of coenzyme Q10 in mitigating spinal cord injury-induced osteoporosis.

  2015cites this paper
• The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study

  2015cites this paper
• Pharmacogenomics of the Drugs used for the Treatment of Thalassemia

  2015cites this paper
• Lung cancer—a fractal viewpoint

  2015cites this paper
• Chapter 23 – Metal Antagonists

  2015cites this paper
• Fibulin-3 is a Novel TGF-β pathway Inhibitor in the Breast Cancer Microenvironment

  2015cites this paper
• The association between BMI and cervical cancer risk: a meta-analysis

  2015cites this paper
• Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.

  2015cites this paper